Advertisement
Screener

aTYR PHARMA INC (ATYR) Net Margin

aTYR PHARMA INC (ATYR) Net Margin

  • 2025-09-30: Net Margin -13549.47%.
  • 2024-03-31: Net Margin -6591.91%.
  • 2023-09-30: Net Margin -3212.46%.
  • 2022-12-31: Net Margin -72.41%.

Complete source-backed net margin history.

Available history
2019-06-30 to 2025-12-31
Data captured

Historical Net Margin

DateNet Margin
2025-09-30-13549.47%
2024-03-31-6591.91%
2023-09-30-3212.46%
2022-12-31-72.41%
2020-12-31-240.23%
2020-09-30-4458.78%
2020-06-30-3410.58%
2020-03-3121.74%
2019-12-31976.39%
2019-09-30-3067.93%
2019-06-30-6221.28%

Annual Net Margin

DateNet Margin
2025-12-31-39009.47%
2024-12-31-27243.83%
2023-12-31-14274.50%
2022-12-31-436.53%
2020-12-31-155.18%
2019-12-31-3844.55%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Scilex Holding Co (SCLX)United States$0.042B-0.14
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
BioCardia, Inc. (BCDA)United States$0.016B